Asthma & Allergies
» 2018 Webinar: Controversies in Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
2018 Webinar: Controversies in Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
November 26, 2018
Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?
Combination Therapy for Invasive Aspergillosis in Patients with Hematologic Malignancies or Hematopoeitic Cell Transplants
PARP in Practice: Expanding Options in the Maintenance Setting for Ovarian Cancer
Post a comment to this article
(will not be displayed)
Report Abusive Comment
Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.